Skip to content

Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients

Efficacy of On-venous Laser Irradiation of Blood on Diabetes Kidney Disease Patients: a Single Center, Randomized, Assessor- and Participant-blind, Controlled, Cross-over Clinical Trial

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06588465
Enrollment
72
Registered
2024-09-19
Start date
2024-07-01
Completion date
2024-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases, Diabetes Mellitus, Proteinuria

Keywords

Chronic Kidney Diseases, diabetes mellitus

Brief summary

The single center, randomized, assessor- and participant-blind, controlled, cross-over on-venous laser irradiation of blood clinical trial was performed to analyze patients with DKD. The information will help to whether integration of laser acupuncture into patient care will help to improve the clinical symptoms and quality of life.

Detailed description

Microalbuminuria is the cardinal symptom of diabetes kidney disease (DKD) and is linked to renal function decline. The cardiovascular risk of patients with DKD is much higher than that of the general population, and cardiovascular diseases is the main cause of death in patients with DKD. We plan to enroll 72 volunteer patients with microalbuminuria. After 1 week waiting period (as the waiting list group), the patients will be randomized to on-venous laser irradiation of blood and low dose OLIB group. Each group will include 36 patients and given intervention three times a week. The intervention will then be crossed over to the other one after 1 week of wash-our period. Outcome measurement includes questionnaires, biochemistry analysis, urine routine analysis.

Interventions

DEVICEOn-venous Laser Irradiation of Blood

The treatment will take place three times a week, over six weeks. The On-venous Laser will placed in the body for 60 minutes. A total of 15 laser heads (15 acupoints, bilaterally) will be used in each session.

DEVICElow dose On-venous Laser Irradiation of Blood

The treatment will take place three times a week, over six weeks. The low dose On-venous Laser will placed in the body for 60 minutes. A total of 15 laser heads (15 acupoints, bilaterally) will be used in each session.

Sponsors

China Medical University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. HbA1C≥6.5 % and ≤ 9%, ±0.5% under past three months 2. eGFR ≥30ml/min/1.73m2 and protinuria ≥30mg/d under ACEI or ARB treatment

Exclusion criteria

1. allergic to laser beans 2. Immunosuppressive drugs had been used in the past six months 3. urine protein over 3.5 g /day 4. Autosomal dominant polycystic kidney disease 5. Lupus nephritis 6. People with mental illness or other mental disabilities are unable to cooperate with the researcher. 7. Those who used non-steroidal analgesics and steroids in the trial period 8. Pregnant or lactating women

Design outcomes

Primary

MeasureTime frameDescription
Examine the spot proteinuria changes between the 6th week and at the time of inclusion, as well as between the 13th week and the 6th week.baseline, 6 weeks, 13weeksA spot urine P/C ratio >20 mg/mmol (0.2 mg/mg) is the most commonly reported cutoff value for detecting proteinuria
Examine the eGFR changes between the 6th week and at the time of inclusion, as well as between the 13th week and the 6th week.baseline, 6 weeks, 13weekseGFR (estimated glomerular filtration rate) is a measure of how well your kidneys are working. Your eGFR is an estimated number based on a blood test and your age, sex, and body type.
Examine the albuminuria changes between the 6th week and at the time of inclusion, as well as between the 13th week and the 6th week.baseline, 6 weeks, 13weeksA ratio of albumin (mcg/L) to creatinine (mg/L) of less than 30 is normal; a ratio of 30-300 signifies microalbuminuria and values above 300 are considered as macroalbuminuria.

Secondary

MeasureTime frameDescription
SF-36baseline, 6 weeks, 13weeks, 17 weeksThe 36-Item Short Form Survey (SF-36) is outcome measure instrument that is often used, well-researched, self-reported measure of health. It stems from a study called the Medical Outcomes Study for the objective measure of the quality of life.It comprises 36 questions that cover eight domains of health

Other

MeasureTime frameDescription
The constitution in Chinese medicine questionnaire (CCMQ)baseline, 6 weeks, 13weeks, 17 weeksThe CCMQ contain 60 items that consist of the following nine major constitution types: Gentleness (8 Items), Qi- deficiency (8 Items), Yang-deficiency (7 Items), Yin-deficiency (8 Items), Phlegm-damp (8 Items), Damp-heat (6 Items), Blood-stasis (7 Items), Qi-depression (7 Items), and special diathesis (7 Items) types.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026